Home › Funds › Flagship Pioneering, LLC › FHTX

Flagship Pioneering, LLC position in FHTX

FOGHORN THERAPEUTICS INC · Health Care

Flagship Pioneering, LLC reported holding 12,674,120 shares of FHTX (FOGHORN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$61.8M, representing 4.02% of its reported portfolio and ranking #4 among its reported holdings. Flagship Pioneering, LLC has disclosed FHTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)12.67M sh
Reported value held$61.85M
Portfolio Weight4.02%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Flagship Pioneering, LLC's FHTX position evolved

Flagship Pioneering, LLC first disclosed a stake in FHTX in Q3 2023 at 12,674,120 shares (US$63.4M). The position peaked in Q3 2024 at 12,674,120 shares, worth US$118.0M. Across 12 filings, Flagship Pioneering, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 12,674,120 shares valued at US$61.8M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.67M $63.37M New
Q4 2023 12.67M $81.75M Hold
Q1 2024 12.67M $85.04M Hold
Q2 2024 12.67M $72.88M Hold
Q3 2024 12.67M $118.00M Hold
Q4 2024 12.67M $59.82M Hold
Q1 2025 12.67M $46.26M Hold
Q2 2025 12.67M $59.57M Hold
Q3 2025 12.67M $61.98M Hold
Q4 2025 12.67M $68.44M Hold
Q1 2026 12.67M $60.58M Hold
Q2 2026 12.67M $61.85M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About FHTX and 13F data

FHTX (FOGHORN THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in FHTX — the largest reported positions include BVF INC/IL (US$28.5M), Euclidean Capital LLC (US$7.7M), Birchview Capital, LP (US$1.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding FHTX

All FHTX fund holders →

FAQ

How long has Flagship Pioneering, LLC held FHTX?

Flagship Pioneering, LLC has disclosed FHTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Flagship Pioneering, LLC's current position in FHTX?

As of Q2 2026, Flagship Pioneering, LLC holds 12.67M shares of FHTX (FOGHORN THERAPEUTICS INC), valued at $61.85M, representing 4.02% of its reported portfolio and ranking #4.

Has Flagship Pioneering, LLC been buying or selling FHTX?

In the latest 13F filing (Q2 2026), Flagship Pioneering, LLC held unchanged its position in FHTX. The position peaked in Q3 2024 at 12.67M shares.

Which other funds hold FHTX?

Other major institutional holders of FHTX include BVF INC/IL, Euclidean Capital LLC, Birchview Capital, LP, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.